FANG AUTOLOGOUS TUMOR CELL VACCINE DEVELOPMENT AND MANUFACTURING
FANG Autologous Tumor Cell Vaccine Development and Manufacturing.
Archive for Publications
CLINICAL CHARACTERIZATION OF THE ADENOVIRUS DEATH PROTEIN-POTENTIATED ONCOLYTIC ADENOVIRUS VRX007
Clinical Characterization of the Adenovirus Death Protein-potentiated Oncolytic Adenovirus VRX007.
CIRCULATING TUMOR CELLS IN PATIENTS UNDERGOING SURGERY FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Circulating Tumor Cells in Patients Undergoing Surgery for Hepatic Metastases from Colorectal Cancer. Baylor University Medical Center Proceedings 2010; 23(1):11-14.
FANG VACCINE: AUTOLOGOUS TUMOR CELL VACCINE GENETICALLY MODIFIED TO EXPRESS GM-CSF AND BLOCK PRODUCTION OF FURIN
FANG Vaccine: Autologous Tumor Cell Vaccine Genetically Modified to Express GM-CSF and Block Production of Furin. BioProcessing Journal 2010; 8(4):4-14.
GENE-BASED THERAPIES FOR LUNG CANCER
In: Lung Cancer: Prevention, Management, and Emerging Therapies. Humana Press, Totowa, NJ; Stewart DJ (ed.), pp. 305-330, 2010.
LUNG CANCER: A MULTIDISCIPLINARY APPROACH TO DIAGNOSIS AND MANAGEMENT
Immunological Approaches to the Treatment of Lung Cancer (Chapter 24). In: Lung Cancer: A Multidisciplinary Approach to Diagnosis and Management.
IN: PRINCIPLES AND PRACTICE OF LUNG CANCER: THE OFFICIAL REFERENCE TEXT OF THE IASLC
n: Principles and Practice of Lung Cancer: The Official Reference Text of the IASLC, Fourth Edition (Chapter 51).
HEREDITARY INCLUSION BODY MYOPATHY: SINGLE PATIENT RESPONSE TO GNE GENE LIPOPLEX THERAPY
Hereditary Inclusion Body Myopathy: Single Patient Response to GNE Gene Lipoplex Therapy. The Journal of Gene Medicine 2010 May; 12(5):403-412.
HEAD AND NECK CANCER: RESPONSE TO P53-BASED THERAPEUTICS
Head and Neck Cancer: Response to p53-Based Therapeutics. Head and Neck 2011; 33(1):131-134.
AUGMENTATION OF DOCETAXEL ANTI-TUMOR ACTIVITY BY A STATHMIN-SPECIFIC BI-FUNCTIONAL SHRNA
Augmentation of docetaxel anti-tumor activity by a stathmin-specific bi-functional shRNA.